Codeine, Aspirin, Apap Formula No. 4

   
Google
 
Web NewDrugInformation.com

Codeine, Aspirin, Apap Formula No. 4


Drug - Codeine, Aspirin, Apap Formula No. 4
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Acetaminophen; Aspirin; Codeine Phosphate
Multiple ingredients are in alphabetical order.

Strength - 150MG;180MG;60MG
The potency of the active ingredient(s), Acetaminophen; Aspirin; Codeine Phosphate. May repeat for multiple part products.

Applicant - SCHERER LABS
The firm name holding legal responsibility for Codeine, Aspirin, Apap Formula No. 4. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 085638
The FDA assigned number to Codeine, Aspirin, Apap Formula No. 4. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Codeine, Aspirin, Apap Formula No. 4. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Codeine, Aspirin, Apap Formula No. 4 was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Codeine, Aspirin, Apap Formula No. 4. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Codeine, Aspirin, Apap Formula No. 4 is in. Format is RX, OTC, DISCN.

Applicant Full Name - Scherer Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Codeine, Aspirin, Apap Formula No. 4.

Codeine, Aspirin, Apap Formula No. 4